Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
ET to report its fourth quarter and full year financial results and provide an update on its business and pipeline.
- ET to report its fourth quarter and full year financial results and provide an update on its business and pipeline.
- To access the call, please dial 1-877-704-4453 (domestic) or 1-201-389-0920 (international) and refer to conference ID 13744458, or click on this Link and request a return call.
- The audio webcast can be accessed on the "Events and Presentations" page under the “Connect” tab of the Company's website at www.sperotherapeutics.com .
- The archived webcast will also be available on Spero's website for 30 days following the call.